Furthermore, studies have reported that TLR4 plays a role in CRC; polymorphisms increasing TLR4 signaling led to a highly aggressive CRC, whereas those reducing TLR4 signaling exerted protective effects [76, 77]. The gene discussed is TLR4; the disease is colorectal carcinoma.